Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02523443 · ClinicalTrials.gov registry record · Phase 3
Patient Controlled Epidural Analgesia Versus Intravenous Patient Controlled Analgesia for Post-Operative Pain Control in Patients Undergoing Elective Liver Resection
A Phase 3 study of Liver Cancer and Pain Management, sponsored by Memorial Sloan Kettering Cancer Center.
- Active
- Registry status
- Phase 3
- Development phase
- 231
- Enrollment target
- 3
- Study locations
NCT02523443: Active Phase 3 study of Liver Cancer and Pain Management, sponsored by Memorial Sloan Kettering Cancer Center.
NCT02523443 is a Phase 3 study of Liver Cancer and Pain Management that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 231 participants, below the 445-participant average among 78 other Liver Cancer trials with a reported enrollment target (48% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02523443, a Phase 3 study of Liver Cancer and Pain Management, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 3
- Development phase
- 231 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this study is to learn whether patient-controlled epidural analgesia (PCEA) is a better method for managing pain after liver resection compared to patient-controlled analgesia (IV PCA). Currently, the standard pain control method for liver resection patients is IV PCA. There is not enough data on how epidural (PCEA) relieves pain and movement on a day to day basis after liver resection.
Primary Outcome
The primary endpoint assesses differences in pain control between PCEA and IV PCA after a "get up and go" test performed on POD2 during pain rounds, evaluated using a NRS pain score.
Conditions Studied
Interventions
- OTHER IV PCA
- OTHER PCEA
Study Locations (3)
New York
- Memorial Sloan Kettering Cancer Center @ Commack (Consent Only) - Commack
- Memorial Sloan Kettering Cancer Center - New York
New Jersey
- Memorial Sloan Kettering Cancer Center (Consent Only) - Basking Ridge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 231 participants |
| Start Date | 2015-08 |
| Est. Completion | 2026-08 |
| Phase | Phase 3 |
What the registry record for NCT02523443 still lists
NCT02523443 is an interventional study that assigns participants to a tested intervention. The registered 231 participants enrollment target is mid-sized for trials with a published cap, below the 445-participant average among 78 other Liver Cancer trials with a reported enrollment target (48% lower).
The record links to 2 conditions, with Liver Cancer appearing as the primary indexed condition, and to 2 interventions - of which IV PCA is the first listed.
NCT02523443 reports a single indexed study location in New York, New Jersey.
Frequently Asked Questions
What is clinical trial NCT02523443 about?
NCT02523443 is a clinical study titled "Patient Controlled Epidural Analgesia Versus Intravenous Patient Controlled Analgesia for Post-Operative Pain Control in Patients Undergoing Elective Liver Resection". The purpose of this study is to learn whether patient-controlled epidural analgesia (PCEA) is a better method for managing pain after liver resection compared to patient-controlled analgesia (IV PCA). Currently, the standard pain control method for liver resection patients is IV PCA. There is not en...
What is the current status of trial NCT02523443?
This trial is currently active not recruiting. It is a Phase 3 study. The enrollment target is 231 participants. The study started on 2015-08. Estimated completion is 2026-08.
What conditions does trial NCT02523443 study?
This clinical trial studies the following conditions: Liver Cancer, Pain Management.
What interventions are being tested in trial NCT02523443?
The interventions under investigation include: IV PCA (OTHER), PCEA (OTHER).
Who is sponsoring clinical trial NCT02523443?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02523443 being conducted?
This trial has 3 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Liver Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02523443's enrollment target sits among peer trials
231 16th of 78 higher than 63 of 78 other Liver Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Liver Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or Ablation
ACTIVE NOT RECRUITING · Phase 3
-
Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers
COMPLETED · Phase 3
-
Feasibility Study of CBCT for IGRT in Cancer Patients
RECRUITING · NA
-
Collection of Blood From Patients With Cancer
RECRUITING
-
National Liver Cancer Screening Trial
RECRUITING · Phase 4
-
vGRID SBRT: A Phase I Clinical Trial in Unresectable or Metastatic HCC
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04077099 · 231 participants · Phase 1
A Study of REGN5093 in Adult Patients With Mesenchymal Epithelial Transition Factor (MET)-Altered Advanced Non-Small Cell Lung Cancer
- NCT05019495 · 231 participants · NA
Optimizing Tobacco Treatment Delivery for People Living With HIV
- NCT06023589 · 231 participants · Phase 3
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
- NCT06734351 · 231 participants · Phase 3
A Study to Evaluate Safety and Effectiveness of NOA VOLUME Injectable Gel in Adult Participants Compared to JUVÉDERM VOLUMA XC for Improvement of Mid-Face Volume
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia